Erin McEvoy

New leadership to the Cannabis Control Board and the Office of Cannabis Management was announced, as well as updates to recent developments in licenses and more.

In this interview clip from our Women in Grow: Leadership in Cannabis Genetics and Cultivation supplement, Anna Schwabe, PhD explains the cannabis projects and companies she is actively involved in, her goals for the future, plus past guests on her podcast, The Dank Hour.

Here, we bring you our top five recent articles covering medical cannabis in Texas, cease-and-desist letter response, pardons in Maryland, cannabis in Thailand, and research on autism and cannabis.

The newly published regulations classify cannabis flowers as controlled herbs, requiring prescriptions and licensed handling.

The acquisition is anticipated to provide a foothold in two states and allow for further expansion in additional locations.

Results included improvements in aggression, hyperactivity, and communication, but a strong placebo effect was also observed.

Industry organizations respond after Governor Greg Abbott vetoed SB 3, citing safety and legal concerns.

Here, we bring you our top five recent articles covering medical cannabis in Hawaii, a new dispensary in Connecticut, pesticide testing in California, a cease-and-desist letter to a dispensary on Long Island, and a global survey on cannabis for endometriosis.

In this interview clip from our Women in Grow: Leadership in Cannabis Genetics and Cultivation supplement, Anna Schwabe, PhD shares insights into genetic characteristics of the cannabis plant and potential research into disease resistance.

The study tested the effects of real-world cannabis products categorized by four modes of administration: dabbing, vaping, bong-like, or joint-like products.

Proposed regulations from the Department of Health would make permanent the emergency rules banning THC in hemp-derived food, beverage, and dietary products while restricting sales to adults 21 and older.

A survey of nearly 900 endometriosis patients across 28 countries highlights cannabis as a preferred alternative to pharmaceuticals, despite legal, social, and medical communication barriers.

Proposed changes include revised action levels for 31 pesticides and the addition of 14 pesticides for required testing.

In this interview clip from our Women in Grow: Leadership in Cannabis Genetics and Cultivation supplement, Anna Schwabe, PhD exlains the cost, services, and benefits of cannabis genotyping.

Here, we bring you our top five recent articles covering safety regulations in North Carolina, licenses in Minnesota, the FDA’s FY2026 Agriculture appropriations bill, cannabis taxes in California, and antifungal properties of CBD and CBDV.

Researchers analyzed national data over a 16-year timeframe to identify who receives treatment for cannabis use disorder (CUD).

Several cease and desist letters were sent to companies in regard to hemp products containing THCA that potentially violate the Missouri Merchandising Practices Act.

With the privatization of its produce business complete, the company intends to focus on global cannabis operations.

The cannabinoids cannabidiol (CBD) and cannabidivarin (CBDV) showed antifungal activity in both in vivo tests and in vitro wound models.

Here, we bring you our top five recent articles covering unlicensed cannabis purchases in New Jersey, cannabis found in Haribo candy, regulating cannabis beverages in Kentucky, appeals court rejects argument against federal prohibition, and organic certification in the industry.

According to two House Bills, medical cannabis must now be sold in pre-packaged form, with new regulations and licenses for transportation, storage, and security of facilities.

The nationwide initiative Mission [Green] supports individuals impacted by cannabis prohibition, and advocates for social justice and equity.

In this interview clip from our Women in Grow: Leadership in Cannabis Genetics and Cultivation supplement, Anna Schwabe, PhD explains mislabeling and record-keeping in the industry.

The law outlines a new framework for the sale of beverages containing intoxicating cannabinoids.

The Court recently published its opinion upholding previous rulings, despite shifting legalization trends in the past two decades.

Here, we bring you our top five recent articles covering a survey on veterans and medical cannabis treatment, a new White Earth dispensary location, New Mexico’s basic income pilot program, social equity licenses in Washington State, and our new podcast episode.

In this month’s webinar, Dustin Sulak, DO, summarizes and provides insights on cannabis studies for chronic pain, restless leg syndrome, insomnia, effects on driving, and more.

Listen to a Noid Factoid from David Sandelman COO, CTO & Co-Founder of Cannatrol.

As Texas advances legislation to ban hemp-derived THC, HB 46 seeks to expand the state’s medical cannabis program, with several recent changes.

Nearly halfway through 2025, let’s revisit what new scientific updates and insights have been happening in the industry.